Harvard Bioscience (Harvard Bioscience) Insider Ownership : 27.18 % (As of May. 26, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Harvard Bioscience Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Harvard Bioscience's insider ownership is 27.18%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Harvard Bioscience's Institutional Ownership is 39.13%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Harvard Bioscience's Float Percentage Of Total Shares Outstanding is 92.96%.

Harvard Bioscience Insider Ownership Historical Data

The historical data trend for Harvard Bioscience's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Insider Ownership Chart

Harvard Bioscience Historical Data

The historical data trend for Harvard Bioscience can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Insider Ownership	26.95	27.01	27.01	27.01	27.01	27.01	26.50	26.50	27.20	27.18

Harvard Bioscience Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Harvard Bioscience (Harvard Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (NAS:HBIO) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

HBI:Germany

Address

84 October Hill Road, Holliston, MA, USA, 01746

Website

https://www.harvardbioscience.com

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Executives

James W Green	director, officer: Chief Executive Officer	12525 CHADRON AVENUE, HAWTHORNE CA 90250
Alan I Edrick	director	20200 SUNBURST STREET, CHATSWORTH CA 91311
Jennifer Cote	officer: Interim CFO	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746
Bertrand Loy	director	C/O ENTEGRIS, INC., 129 CONCORD RD, BILLERICA MA 01821
Thomas W Loewald	director	81 WYMAN STREET, WALTHAM MA 02451
John F Kennedy	director	C/O NET PERCEPTIONS INC, 7700 FRANCE AVE. SOUTH, EDINA MN 55435
Katherine A. Eade	director	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Susan M. Steele	director	C/O HILL INTERNATIONAL, INC., 2005 MARKET ST., 17TH FLOOR, PHILADELPHIA PA 19103
Kenneth Fletcher Olson	officer: Chief Operating Officer	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Michael A. Rossi	officer: Chief Financial Officer	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Yash Singh	officer: Executive Vice President	C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD #10, HOLLISTON MA 01746
Jeffrey Duchemin	officer: Chief Executive Officer	14 EASTLAND TERRACE, HAVERHILL MA 01830
Kamalam Unninayar	officer: Chief Financial Officer	C/O TETRAPHASE PHARMACEUTICALS, INC., 480 ARSENAL STREET, SUITE 110, WATERTOWN MA 02472
Robert E. Gagnon	officer: Chief Financial Officer	C/O BIOGEN IDEC INC., 133 BOSTON POST ROAD, WESTON MA 02493
George Uveges	director	C/O MFIC CORPORATION, 30 OSSIPEE ROAD, NEWTON MA 02464